Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 10-Aug-23 4:05 PM View:  | Aptevo Therapeutics Inc. (APVO) | 09-Aug-23 | Option Exercise | 3,571 | -- | -- | 75% 4.77K to 8.34K | |
| 02-Jun-23 4:43 PM View: | Aptevo Therapeutics Inc. (APVO) | 01-Jun-23 | Option Exercise | 297 | -- | -- | 7% 4.47K to 4.77K | |
| 03-Jun-22 3:16 PM View: | Aptevo Therapeutics Inc. (APVO) | 01-Jun-22 | Option Exercise | 298 | -- | -- | 4% 7.81K to 8.11K | |
| 25-Jun-19 7:11 PM View: | Aptevo Therapeutics Inc. (APVO) | 25-Jun-19 | Market Purchase | 16,667 | $0.90 | $15,000.30 | 18% 92.68K to 109.35K | 3863% |
| 04-Mar-19 6:39 PM View: | Emergent BioSolutions, Inc. (EBS) | 04-Mar-19 | Market Sale (Planned) | 14,565 | $58.11 | $846,328.00 | (9%) 159.12K to 144.55K | (64%) |
| 28-Feb-19 7:03 PM View: | Emergent BioSolutions, Inc. (EBS) | 28-Feb-19 | Payment of Exercise | 5,101 | $58.71 | $299,480.00 | (3%) 164.22K to 159.12K | (62%) |
| 28-Feb-19 7:03 PM View: | Emergent BioSolutions, Inc. (EBS) | 27-Feb-19 | Payment of Exercise | 2,570 | $57.98 | $149,009.00 | (2%) 166.79K to 164.22K | (64%) |
| 28-Feb-19 7:03 PM View: | Emergent BioSolutions, Inc. (EBS) | 26-Feb-19 | Payment of Exercise | 1,714 | $61.01 | $104,571.00 | (1%) 168.5K to 166.79K | (56%) |
| 18-Sep-18 4:09 PM View: | Emergent BioSolutions, Inc. (EBS) | 17-Sep-18 | Option Exercise | 1,319 | $13.38 | $17,648.20 | < 1% 168.5K to 169.82K | |
| 18-Sep-18 4:09 PM View: | Emergent BioSolutions, Inc. (EBS) | 17-Sep-18 | Market Option Sale (Planned) | 1,319 | $65.00 | $85,735.00 | (< 1%) 169.82K to 168.5K | (46%) |
| 18-Sep-18 4:09 PM View: | Emergent BioSolutions, Inc. (EBS) | 14-Sep-18 | Option Exercise | 28,220 | $13.38 | $377,584.00 | 17% 168.5K to 196.72K | |
| 18-Sep-18 4:09 PM View: | Emergent BioSolutions, Inc. (EBS) | 14-Sep-18 | Market Option Sale (Planned) | 28,220 | $65.00 | $1,834,300.00 | (14%) 196.72K to 168.5K | (46%) |
| 06-Sep-18 5:51 PM View: | Emergent BioSolutions, Inc. (EBS) | 05-Sep-18 | Market Sale (Planned) | 30,776 | $59.49 | $1,830,940.00 | (15%) 199.28K to 168.5K | (60%) |
| 06-Sep-18 5:51 PM View: | Emergent BioSolutions, Inc. (EBS) | 04-Sep-18 | Option Exercise | 60,000 | $13.38 | $802,800.00 | 30% 199.28K to 259.28K | |
| 06-Sep-18 5:51 PM View: | Emergent BioSolutions, Inc. (EBS) | 04-Sep-18 | Market Option Sale (Planned) | 60,000 | $60.54 | $3,632,290.00 | (23%) 259.28K to 199.28K | (57%) |
| 07-Jun-18 5:07 PM View: | Emergent BioSolutions, Inc. (EBS) | 05-Jun-18 | Market Sale | 15,785 | $52.11 | $822,615.00 | (7%) 215.06K to 199.28K | (82%) |
| 13-Mar-18 5:53 PM View: | Emergent BioSolutions, Inc. (EBS) | 09-Mar-18 | Payment of Exercise | 7,825 | $51.84 | $405,648.00 | (4%) 222.89K to 215.06K | (83%) |
| 01-Mar-18 5:01 PM View: | Emergent BioSolutions, Inc. (EBS) | 28-Feb-18 | Payment of Exercise | 6,599 | $49.97 | $329,752.00 | (3%) 229.49K to 222.89K | (90%) |
| 01-Mar-18 5:01 PM View: | Emergent BioSolutions, Inc. (EBS) | 27-Feb-18 | Grant | 26,742 | -- | -- | 13% 206.07K to 232.81K | |
| 01-Mar-18 5:01 PM View: | Emergent BioSolutions, Inc. (EBS) | 27-Feb-18 | Payment of Exercise | 3,324 | $49.64 | $165,003.00 | (1%) 232.81K to 229.49K | (92%) |
| 04-Jan-18 4:31 PM View: | Emergent BioSolutions, Inc. (EBS) | 02-Jan-18 | Option Exercise | 21,906 | $14.44 | $316,323.00 | 11% 205.13K to 227.04K | |
| 04-Jan-18 4:31 PM View: | Emergent BioSolutions, Inc. (EBS) | 02-Jan-18 | Market Option Sale (Planned) | 21,906 | $47.91 | $1,049,520.00 | (10%) 227.04K to 205.13K | (98%) |
| 14-Dec-17 4:57 PM View: | Emergent BioSolutions, Inc. (EBS) | 13-Dec-17 | Option Exercise | 20,000 | $14.44 | $288,800.00 | 10% 205.13K to 225.13K | |
| 14-Dec-17 4:57 PM View: | Emergent BioSolutions, Inc. (EBS) | 13-Dec-17 | Market Option Sale (Planned) | 20,000 | $45.99 | $919,800.00 | (9%) 225.13K to 205.13K | (107%) |
| 07-Nov-17 4:07 PM View: | Emergent BioSolutions, Inc. (EBS) | 03-Nov-17 | Option Exercise | 31,508 | $17.21 | $542,321.00 | 15% 205.13K to 236.64K | |
| 07-Nov-17 4:07 PM View: | Emergent BioSolutions, Inc. (EBS) | 03-Nov-17 | Market Option Sale (Planned) | 31,508 | $42.77 | $1,347,490.00 | (13%) 236.64K to 205.13K | (122%) |
| 29-Sep-17 4:36 PM View: | Emergent BioSolutions, Inc. (EBS) | 27-Sep-17 | Option Exercise | 15,000 | $22.03 | $330,450.00 | 7% 205.13K to 220.13K | |
| 29-Sep-17 4:36 PM View: | Emergent BioSolutions, Inc. (EBS) | 27-Sep-17 | Market Option Sale (Planned) | 15,000 | $39.92 | $598,770.00 | (7%) 220.13K to 205.13K | (138%) |
| 05-Sep-17 5:16 PM View: | Emergent BioSolutions, Inc. (EBS) | 31-Aug-17 | Option Exercise | 15,000 | $22.03 | $330,450.00 | 7% 204.13K to 219.13K | |
| 05-Sep-17 5:16 PM View: | Emergent BioSolutions, Inc. (EBS) | 31-Aug-17 | Market Option Sale (Planned) | 15,000 | $37.21 | $558,150.00 | (7%) 219.13K to 204.13K | (155%) |
| 10-Mar-17 9:10 PM View: | Emergent BioSolutions, Inc. (EBS) | 10-Mar-17 | Payment of Exercise | 10,738 | $31.05 | $333,415.00 | (5%) 214.87K to 204.13K | (206%) |
| 10-Mar-17 9:10 PM View: | Emergent BioSolutions, Inc. (EBS) | 09-Mar-17 | Payment of Exercise | 8,226 | $30.98 | $254,841.00 | (4%) 223.1K to 214.87K | (207%) |
| 02-Mar-17 9:29 PM View: | Emergent BioSolutions, Inc. (EBS) | 28-Feb-17 | Grant | 39,177 | -- | -- | 21% 190.1K to 229.28K | |
| 02-Mar-17 9:29 PM View: | Emergent BioSolutions, Inc. (EBS) | 28-Feb-17 | Payment of Exercise | 6,184 | $30.63 | $189,416.00 | (3%) 229.28K to 223.1K | (210%) |
| 01-Mar-17 8:26 PM View: | Emergent BioSolutions, Inc. (EBS) | 27-Feb-17 | Payment of Exercise | 1,735 | $30.63 | $53,143.00 | (< 1%) 192.82K to 191.09K | (210%) |
| 01-Mar-17 8:26 PM View: | Emergent BioSolutions, Inc. (EBS) | 27-Feb-17 | Payment of Exercise | 984 | $30.63 | $30,139.90 | (< 1%) 191.09K to 190.1K | (210%) |
| 01-Mar-17 8:26 PM View: | Emergent BioSolutions, Inc. (EBS) | 27-Feb-17 | Option Exercise | 3,662 | $30.63 | $112,167.00 | 2% 189.16K to 192.82K | 210% |
| 12-Jan-17 9:59 PM View: | Emergent BioSolutions, Inc. (EBS) | 10-Jan-17 | Option Exercise | 38,006 | $14.51 | $551,467.00 | 21% 179.4K to 217.4K | |
| 12-Jan-17 9:59 PM View: | Emergent BioSolutions, Inc. (EBS) | 10-Jan-17 | Market Option Sale (Planned) | 28,240 | $31.28 | $883,296.00 | (13%) 217.4K to 189.16K | (204%) |
| 12-Jan-17 9:59 PM View: | Emergent BioSolutions, Inc. (EBS) | 01-Aug-16 | Acquisition (other) | 8,430 | -- | -- | 5% 170.97K to 179.4K | |
| 03-Jun-16 7:28 AM View: | Emergent BioSolutions, Inc. (EBS) | 01-Jun-16 | Market Sale | 8,699 | $43.74 | $380,494.00 | (5%) 179.66K to 170.97K | (106%) |
| 24-May-16 4:58 PM View: | Emergent BioSolutions, Inc. (EBS) | 20-May-16 | Market Sale | 8,701 | $42.00 | $365,442.00 | (5%) 188.37K to 179.66K | (114%) |
| 20-Apr-16 11:14 AM View: | Emergent BioSolutions, Inc. (EBS) | 18-Apr-16 | Market Sale | 8,702 | $40.17 | $349,559.00 | (4%) 197.07K to 188.37K | (124%) |
| 05-Apr-16 3:25 PM View: | Emergent BioSolutions, Inc. (EBS) | 11-Mar-16 | Payment of Exercise | 6,493 | $34.22 | $222,190.00 | (3%) 203.56K to 197.07K | (163%) |
| 11-Mar-16 3:42 PM View: | Emergent BioSolutions, Inc. (EBS) | 10-Mar-16 | Payment of Exercise | 9,794 | $34.38 | $336,718.00 | (5%) 213.35K to 203.56K | (162%) |
| 11-Mar-16 3:42 PM View: | Emergent BioSolutions, Inc. (EBS) | 09-Mar-16 | Payment of Exercise | 7,484 | $34.60 | $258,946.00 | (3%) 220.84K to 213.35K | (160%) |
| 03-Mar-16 9:19 AM View: | Emergent BioSolutions, Inc. (EBS) | 01-Mar-16 | Grant | 35,471 | -- | -- | 19% 185.37K to 220.84K | |
| 28-Dec-15 2:20 PM View: | Emergent BioSolutions, Inc. (EBS) | 24-Dec-15 | Option Exercise | 22,855 | $18.90 | $431,960.00 | 12% 185.37K to 208.22K | |
| 28-Dec-15 2:20 PM View: | Emergent BioSolutions, Inc. (EBS) | 24-Dec-15 | Market Option Sale | 22,855 | $39.17 | $895,230.00 | (11%) 208.22K to 185.37K | (130%) |
| 28-Dec-15 2:20 PM View: | Emergent BioSolutions, Inc. (EBS) | 23-Dec-15 | Option Exercise | 40,354 | $18.90 | $762,691.00 | 22% 185.37K to 225.72K |